WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

WuXi Biologics (Cayman) Inc.

Pharma Manufacturing provides information and resources related to the pharmaceutical manufacturing sector, including industry news, articles, and events.

Pharma Manufacturing

HERMED Technische Beratungs GmbH is a consulting and service company for the economic and legally secure management of medical technology in healthcare.

HERMED Technische Beratungs GmbH

medres - medical research GmbH conducts medical research aimed at practical applications in the economy.

medres - medical research GmbH

WuXi Biologics provides contract research, development, and manufacturing services for biologics, offering end-to-end solutions from discovery to commercialization.

Metric
Company Name	WuXi Biologics (Cayman) Inc.	Pharma Manufacturing	HERMED Technische Beratungs GmbH	medres - medical research GmbH
Symbol	2.27K
MSH ID	COM:WUXIBIOLOGICS	COM:PHARMAMANUFACTURING	DE:HERMED	DE:MEDRES
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Commercial & Professional Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Pharmaceuticals	Medical Technology	Medical Research
Country	CN	US	DE	DE
Stage	Venture Round
Employee Count	12.74K
Website	wuxibiologics.com	pharmamanufacturing.com	hermed.de	medres.de
LinkedIn
Founders

Metric
Market Cap	5.94B
Enterprise Value
Monthly Web Traffic	161.84K	6.54K
Web Traffic Growth	0.26	-0.82
Valuation
Raised Capital

Metric
Revenue	2.34B
Revenue (LTM)
Revenue (NTM)
Gross Profit	939.15M
EBITDA	639.78M
Operating Income	540.93M
Net Income	467.62M
EPS	0.11
Diluted EPS	0.11
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.42
Operating Profit Margin	0.25
EBITDA Margin	0.27
Net Profit Margin	0.25
Return on Equity	0.11
Return on Assets	0.08
Return on Capital Employed	0.09

2269

COM:WUXIBIOLOGICS

WuXi Biologics

Last Close

14.40

25/11 08:08

Market Cap

46.18B

Beta: -

Volume Today

45.60M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	32.40
P/B Ratio	1.85
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	6.71
EV Multiple	26.82

Metric
Days Sales Outstanding
Days Payables Outstanding	39.40
Days Inventory Outstanding	83.26
Operating Cycle	259.78
Cash Conversion Cycle	220.49
Asset Turnover	0.32

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt	0.95
Operating Cash Flow/Sales	0.29
Free Cash Flow Yield	0.01

Metric
Cash & Equivalents	1.33B
Accounts Receivable
Inventory	242.87M
Goodwill	210.43M
Debt to Capitalization	0.12
Debt to Assets	0.10
Current Ratio	2.20
Quick Ratio	2.62

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.09
R&D to Revenue	0.05
SG&A to Revenue	0.09